FinTechsDepot FinTechsDepot - Empowering FinTech Futures: Where Knowledge Fuels Innovation.

  • HOME
  • ARTICLES
    • Digital banking
  • RESOURCES
    • Whitepaper
    • Infographics
  • GLOBENEWSWIRE NEWS
  • EVENTS
    • Upcoming conference
    • Past Conference
    • Webinar
  • Contact Us
FinTechsDepot
  • Home
  • Admin
  • Page 6

Author

Admin 422 posts 0 comments

Whitepaper

Immersive Banking: A New Paradigm for Customer Engagement in Financial Services

Admin Feb 19, 2026
As immersive technologies evolve primarily powered by investments from big techs like Apple (Apple placing its…
Whitepaper

Building a Better Banking Ecosystem with Modern Network Connectivity

Admin Feb 18, 2026
The technology infrastructure most businesses rely on is rapidly transforming, with the cloud and AI-driven…
Whitepaper

ECMS: a game changer to access your central bank

Admin Feb 17, 2026
Central banks play an important role in ensuring sufficient liquidity is available for financial markets.…
Whitepaper

How Your Personality Is Impacting Your Finances

Admin Feb 16, 2026
Your personality impacts how you make decisions in almost every area of your life. Your career, relationships,…
Whitepaper

Value-Driven Experiences Led by API in Fintech

Admin Feb 13, 2026
As a growing number of consumers and businesses incorporate web and mobile apps into their daily routines,…
Articles

Which financial companies are leading the way in AI?

Admin Feb 12, 2026
Artificial Intelligence (AI) isn’t just a buzzword in the financial world — it’s transforming practically every…
Infographics

Why Investors Should Rethink Traditional Income Strategies

Admin Feb 11, 2026
Today's infographic shows why traditional longer-term bonds are no longer as effective, so which additional income…
Whitepaper

The Future of Private Assets in Retail Investors’ Portfolios

Admin Feb 2, 2026
Asset managers headquartered in Europe saw their private market assets continue to grow, albeit more slowly than…
Whitepaper

Reduce Paper & Costs With AP Automation

Admin Jan 30, 2026
Manual accounts payable (AP) processes are costly, inefficient, and expose companies to unnecessary risk. With the…
Whitepaper

From Enablement to Growth: AI’s Role in Wealth Management Success

Admin Jan 29, 2026
Wealth management firms face new pressures from complex products, higher client expectations, and regulations.…
Older Posts
Newer Posts

    SUBSCRIBE NOW


    Via Email
    Via Telephone


    I Agree. I would like to share my information with FinTechsDepot & their partners so that I can receive relevant information about products, services, & offers.

    RECENT POST

    • Everything You Should Know About Contactless Payments
    • Embedded banking but not as you know it
    • How Smart Money Management and Digital Trends Are Reshaping Wealth in 2026
    • INVESTMENT GUIDE Investing for your future
    • 5 Approaches to Scaling Finance Accuracy with AI

    ARTICLE

    Comprehensive Healthcare Names New COO and CHRO to Strengthen Growing Organization
    2026-05-13T16:00:00Z
    YAKIMA, Wash., May 13, 2026 (GLOBE NEWSWIRE) -- Comprehensive Healthcare, the leading community behavioral health provider in central and southwest Washington, today announced a promotion and an addition to its...


    Berry Street Partners with Factor, Bringing Personalized Nutrition Therapy to Leading Meal Delivery Service
    2026-05-13T16:00:00Z
    Factor’s expansive customer base can now work with expert Registered Dietitians who see their actual meal choices, turning every session into targeted recommendations


    ONWARD Medical Announces Results of the 2026 Annual General Meeting of Shareholders
    2026-05-13T15:57:15Z
    THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)


    EUROAPI statement regarding the Brindisi site
    2026-05-13T15:45:00Z
    Paris – May 13, 2026 – EUROAPI takes note of local media reports regarding its Brindisi site.


    BioRestorative Therapies Presents New Preclinical Data at ISCT 2026 Highlighting Source-Specific Exosome Functionality and Commercial Applications in BioCosmeceuticals
    2026-05-13T15:00:00Z
    Data demonstrate distinct functional signatures across MSC-derived extracellular vesicles supporting targeted regenerative and aesthetic applications


    Eric Palmer Joins AMN Healthcare Board of Directors
    2026-05-13T14:02:00Z
    DALLAS, May 13, 2026 (GLOBE NEWSWIRE) -- AMN Healthcare, the leader and innovator in total talent solutions for healthcare organizations, announced the election of Eric Palmer to its Board of...


    Sapu Nano Announces First Patient Dosed in Phase 1b Trial of Sapu003, an Intravenous Deciparticle™ Formulation of Everolimus
    2026-05-13T14:00:00Z
    First-in-human study evaluates weekly IV Sapu003 in advanced mTOR-sensitive solid tumors, including HR+/HER2- breast cancer, RCC, NETs, TSC-associated tumors, and HCC


    USOSM Secures Partnership with Hudson Valley Oral Surgery
    2026-05-13T13:47:00Z
    IRVING, Texas, May 13, 2026 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management (USOSM) – a management services organization that exclusively serves premier oral and maxillofacial surgeons –has secured a new...


    Noted Vaccine Researchers Uğur Şahin and Özlem Türeci Awarded Sabin Vaccine Institute’s Albert B. Sabin Gold Medal; Genomic Scientist Senjuti Saha of Bangladesh Receives Rising Star Award
    2026-05-13T13:41:04Z
    WASHINGTON, May 13, 2026 (GLOBE NEWSWIRE) -- The 2026 Sabin Awards were presented yesterday at the National Academy of Sciences building in Washington, D.C., with Professor Uğur Şahin, MD, and...


    Polyrizon Advances Towards Human Clinical Trials: Secures First U.S. Clinical Site for NASARIX™ Allergy Blocker Clinical Trial
    2026-05-13T13:25:00Z
    Raanana, Israel, May 13, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, today announced...


    Onconetix Reports Q1 2026 Progress at Proteomedix AG, Including Two New Peer-Reviewed Publications and Initiation of U.S. Validation Study
    2026-05-13T13:25:00Z
    New Clinical Data Reinforce Proclarix® Performance in Reducing Overdiagnosis and Unnecessary Biopsies; Multi-Center PRIME Study Initiated in Collaboration with Labcorp; European Commercial Expansion Advances


    SafeSpace Global Corp. (OTCID: SSGC) to Participate in Nashville AI Week; President & CSO Dustin Hillis Scheduled for Multiple Speaking Engagements
    2026-05-13T13:15:00Z
    Knoxville, TN., May 13, 2026 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation ("SafeSpace" or the "Company") (OTCID: SSGC), a provider of multimodal AI-powered physical safety and security technologies designed to enhance...


    The Plastic Crisis Is Exploding and Kraig Biocraft Laboratories Has a Unique Answer
    2026-05-13T13:05:00Z
    The World’s Plastic Addiction Is Becoming an Economic and Environmental Disaster, and Biomaterials could become the Ultimate Replacement


    Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter
    2026-05-13T13:00:00Z
    -- New catheter complements FemVue® and supports streamlined in-office fertility evaluation --


    Vicarious Surgical Demonstrates Sustained System Performance and Complex Hernia Procedure Workflows in Pre-Clinical Setting
    2026-05-13T13:00:00Z
    Company Remains on Track For Design Freeze by End of Year 2026


    Chemed Corporation to Present at the 2026 RBC Global Healthcare Conference
    2026-05-13T13:00:00Z
    CINCINNATI, May 13, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 20,...


    Biofrontera Launches Second Annual “Hats On” Campaign to Raise Awareness of Actinic Keratosis
    2026-05-13T13:00:00Z
    Woburn, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), today...


    Neomorph Appoints Biopharma Leader Robert J. Hugin as Chairman of the Board
    2026-05-13T13:00:00Z
    SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Neomorph, Inc., a biotechnology company advancing a new class of molecular glue degraders to target historically undruggable proteins, today announced the appointment...


    Sharecare joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation
    2026-05-13T13:00:00Z
    American Heart Association consortium advances development of evidence-based health tech solutions


    Cannabix Marijuana Breath Test Achieves Major Milestone: Breath Collection Unit Secures UL and CSA Certifications
    2026-05-13T12:45:00Z
    VANCOUVER, British Columbia, May 13, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) is pleased to announce that its portable Breath...


    Anteris Appoints Susan Knight and Stephen Denaro to its Board of Directors
    2026-05-13T12:39:40Z
    MINNEAPOLIS and BRISBANE, Australia, May 13, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing,...


    Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
    2026-05-13T12:30:00Z
    BOSTON, May 13, 2026 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced that,...


    Rectify Pharmaceuticals to Present Preclinical Data on New Dual Targeted ABCB4/BSEP Positive Functional Modulator at EASL 2026
    2026-05-13T12:30:00Z
    Data highlight RTY-406's dual ABCB4/BSEP mechanism and marks the first demonstration of proof of mechanism in a non-human primate model that closely mirrors the human hepatobiliary system


    Amlogenyx Presents Preclinical Data on AM805, a Potentially Transformative Investigational Gene Therapy for Alzheimer’s Disease
    2026-05-13T12:30:00Z
    A novel approach using a lysosomal enzyme to prevent and reverse amyloid accumulation inside as well as outside neurons, with greater potency, delivered in a one-time gene therapy


    SS Innovations Reports First Quarter 2026 Financial Results
    2026-05-13T12:30:00Z
    Record quarterly revenue driven by strong growth in SSi Mantra installations and procedures


    Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities
    2026-05-13T12:30:00Z
    AUSTIN, Texas, May 13, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Obesity and type 2 diabetes mellitus (T2DM) rank among the most urgent and costly healthcare problems facing the world...


    Real-Time Intoxication Detection Platforms Target Expanding Multibillion-Dollar Healthcare Opportunities
    2026-05-13T12:30:00Z
    AUSTIN, Texas, May 13, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: For decades, reliably identifying drug and alcohol impairment has been a persistent problem across industries, from traffic enforcement and...


    CNS Drug Delivery Technologies Are Reshaping Alzheimer’s and Biodefense Research
    2026-05-13T12:30:00Z
    AUSTIN, Texas, May 13, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Among the most guarded structures in human biology, the brain is also one of the hardest to treat. The...


    PharmAla Biotech Executes Definitive Agreement to Form Special Purpose Vehicle, Restora Neurosciences, for Clinical Development of Patented Novel MDXX Molecule APA-01
    2026-05-13T12:30:00Z
    TORONTO, May 13, 2026 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (CSE: MDMA) (OTCQB: MDXXF) (“PharmAla” or the “Company”), a leader in the research, development, and manufacturing of clinical-grade MDMA...


    Fate Therapeutics Reports First Quarter 2026 Financial Results and Business Updates
    2026-05-13T12:30:00Z
    RECLAIM – LN, a Phase 2 potentially registrational clinical trial of FT819 in patients with refractory moderate-to-severe systemic lupus erythematosus (SLE) with lupus nephritis, on schedule to initiate in the...

    Copyright © 2026 | FinTechsDepot | All Rights Reserved |
    Privacy Policy | Unsubscribe
    Sign in

    Welcome, Login to your account.

    Forget password?
    Sign in

    Recover your password.

    A password will be e-mailed to you.